ANALYTICAL REPORT 1 5F-AKB48 (C23H30FN3O) N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3 carboxamide

Similar documents
ANALYTICAL REPORT. 5C-AKB48 (C23H30ClN3O) powder - white Sample type: Comments 1 : Remark other NPS detected: none

ANALYTICAL REPORT. Flubromazepam (C15H10BrFN2O) powder - white

ANALYTICAL REPORT 1 5F-APP-PICA(PX1) (C23H26FN3O2) N-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide

ANALYTICAL REPORT 1 AKB-57 (C23H30N2O2) adamantan-1-yl 1-pentyl-1H-indazole-3-carboxylate.

ANALYTICAL REPORT 1 FUB-AMB ( C21H22FN3O3) methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate

ANALYTICAL REPORT. Isopropyl-U (C18H26Cl2N2O) 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-(propan-2-yl)benzamide

ANALYTICAL REPORT 1. 4-CIC (C12H16ClNO) 1-(4-chlorophenyl)-2-(isopropylamino)propan-1-one.

ANALYTICAL REPORT 1. 4Cl-PVP (C15H20ClNO) Remark other NPS detected: none. 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one. Sample ID:

ANALYTICAL REPORT 1. 4-CEC (C11H14ClNO) Remark other NPS detected: none. 1-(4-chlorophenyl)-2-(ethylamino)propan-1-one. Sample ID:

ANALYTICAL REPORT 1. alpha-php (C16H23NO) 1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.

ANALYTICAL REPORT 1 MDMB-CHMCZCA (C27H34N2O3) methyl-2-(1-(cyclohexylmethyl)-9h-carbazol-3-ylcarbonylamino)-3,3-dimethylbutanoate

ANALYTICAL REPORT MDPHP (C17H23NO3) powder - brown dark Sample type: Comments 1 : Remark other NPS detected: Sample ID: Sample description:

ANALYTICAL REPORT 1. RTI-111 (C16H19Cl2NO2) methyl 3-(3,4-dichlorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate

ANALYTICAL REPORT THF-F (C24H30N2O2) N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide

ANALYTICAL REPORT 1. Methoxyacetyl-F (C22H28N2O2) 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide

ANALYTICAL REPORT 1. 3-MeO-PCP (C18H27NO) Remark other NPS detected: none. 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine. Sample ID:

ANALYTICAL REPORT 1 CUMYL-4CN-BINACA (C22H24N4O) 1-(4-cyanobutyl)-N-(1-methyl-1-phenylethyl)-1H-indazole-3-carboxamide

Acknowledgement: 4F-PBP (C14H18FNO) T: +386 (0) E: Vodovodna Ljubljana SLOVENIJA

ANALYTICAL REPORT 1. 4-Me-TMP (C15H21NO2) Remark other NPS detected: none. sample contains some impurities (benzeneacetic acid + others)

ANALYTICAL REPORT 1 1P-LSD (C23H29N3O2) N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-

ANALYTICAL REPORT 1 25I-NBOH (C17H20INO3) 2-({[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol

ANALYTICAL REPORT. 25B-NBOH (C17H20BrNO3) 2-({[2-(4-bromo-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol RSUNJYKZRKIBNB-UHFFFAOYSA-N

Supporting Information

Preparation of endohedral fullerene containing lithium 60 ) and isolation as pure hexafluorophosphate salt ([Li 60 ][PF 6 ])

High-resolution probes for 19 F applications. Aitor Moreno Bruker BioSpin, Switzerland BeNeLux NMR User Meeting 2016, Brussels 25 th of November 2016

Supporting Information

Diels-Alder Approach to Biaryls (DAB): Importance of the ortho-nitro Moiety in the [4+2] Cycloaddition.

Supplementary Information UNEXPECTED REDUCTION OF INDOLE DOUBLE BOND IN MITRAGYNINE USING N-BUTYLSILANE AND CATALYTIC TRIS(PENTAFLOROPHENYL)BORANE

Gulaim A. Seisenbaeva,, Geoffrey Daniel, Jean-Marie Nedelec,, Vadim G. Kessler,*, Supplementary materials

Supporting Information. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, 2008

Asymmetric Hydrogenation of Imines with Recyclable Chiral Frustrated Lewis Pair Catalyst

-SUPPORTING INFORMATION-

Chemical characterizations and reporting of new psychoactive substances RESPONSE project methodologies

Indigenous development of Novel Magnesium Precursor and High Performance Ziegler-Natta Catalysts for Polypropylene & Polyethylene

AstraZeneca, Pharmaceutical Sciences, Silk Road Business Park, Macclesfield, SK10 2NA, UK

MassHunter METLIN Metabolite PCD/PCDL Quick Start Guide

Synthesis, Characterization and Antimicrobial screening of some Azo compounds derived from Ethyl vanillin

Supporting Information. Solvent-Coordinated Tin Halide Complexes as Purified Precursors for Tin-based Perovskites

1. GENERAL INFORMATION IUPAC

5Cl-AKB48 and 5Br-AKB48

Final Report. Characterisation of Sample Report. Job No 2016/11/12-34 AS No. 1234A. Client Example Contact Sample. Signed Date 2017.

2,5-DIMETHOXY-4-IODOPHENETHYLAMINE Latest Revision: August 22, 2005

SUPPORTING INFORMATION. Titania-Catalyzed Radiofluorination of Tosylated Precursors in Highly Aqueous Medium

Asymmetric Michael Reaction of Aldehydes and Nitroalkenes

Analysis of Gamma butyrolactone for registration according REACH. Report no. JK 75/17

Agilent G3212 GC-APCI Source

Accurate Mass Analysis of Hydraulic Fracturing Waters: Identification of Polyethylene Glycol Surfactants by LC/Q-TOF-MS

Pharmaceutical Impurity Identification and Profiling Using Agilent Q-TOF LC/MS Combined with Advanced MassHunter Data Processing Software

Accurate Mass Analysis of Hydraulic Fracturing Waters

Selective Formation of Benzo[c]cinnoline by Photocatalytic Reduction of 2,2 Dinitrobiphenyl with TiO 2 and UV light irradiation

Agilent 1290 Infinity Quaternary LC Stepwise Transfer to Methods with MS-Compatible Mobile Phases

PI(17:0/14:1(9Z)) (Proton Form) (Ammonium salt Form) (Proton Form) (Ammonium salt Form) LMGP / LM7-112B

Supporting Information. Enantioselective Organocatalyzed Henry Reaction with Fluoromethyl Ketones

Analyte Targeting for NPS Identification in Seized Drugs and Toxicology

Certified Reference Material - Certificate of Analysis Methylone, Primary Standard

Determination of EU-Banned Disperse Dyes by LC/MSD TOF Application

Supporting Information

The Focus Robotic Sample Processor as a Tool for the Multiple Analysis of Samples using Complementary Techniques

2017 Reaction of cinnamic acid chloride with ammonia to cinnamic acid amide

Supporting Information

An Effective Workflow for Impurity Analysis Incorporating High Quality HRAM LCMS & MSMS with Intelligent Automated Data Mining

High-Resolution Sampling 2D-LC for Pharmaceutical Impurity Analysis

Certified Reference Material - Certificate of Analysis

Mass Spectrometry Reference Standard 1-Heptadecanoyl-2-(5Z,8Z,11Z,14Z-Eicosatetraenoyl)-sn-Glycero-3-Phospho- (1 -Myo-Inositol)(Ammonium Salt)

Evaluation of bishexadecyltrimethyl ammonium palladium tetrachloride based dual. functional colloidal carrier as an antimicrobial and anticancer agent

Screening of Pharmaceuticals and Personal Care Products in Effluents and Surface Waters with LCMS Q-TOF

Supplementary Information. Low volume shrinkage polymers by photo Polymerization of 1,1- Bis(ethoxycarbonyl)-2-vinylcyclopropanes

BUFOTENINE Latest Revision: August 16, 2005

Red Color CPL Emission of Chiral 1,2-DACH-based Polymers via. Chiral Transfer of the Conjugated Chain Backbone Structure

The Agilent 1260 Infinity Analytical SFC System with Time-of-Flight Mass Spectrometric Detection

Contents. Efficient synthesis of 5-(chloromethyl)furfural (CMF) from high fructose corn syrup (HFCS) using continuous flow processing

Application Note. Edgar Naegele. Abstract

Rapid method development to study plasma stability of diverse pharmaceutical compounds using Rapid Resolution LC and triple quadrupole MS

Methyl 1-[(4-fluorophenyl)methyl]indazole-3-carboxylate

Clinical Toxicology. Biomass Component Extraction: The uneaten cooked plant specimen was prepared for

Joint Research Centre. The European Commission's in-house science service

Array-Based Sensing of Explosives by Water- Soluble Poly(para-phenyleneethynylene)s

5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE Latest Revision: June 20, 2005

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

The Agilent InfinityLab 2D-LC Solution with Active Solvent Modulation

2-[[2-(4-ethyl-2,5-dimethoxy-phenyl)ethylamino]methyl]phenol

GC-CI-MS analysis of TMS derivatives

4-Methyldiethcathinone (4-MDEC)

(proton form) (ammonium salt) (proton form) (ammonium salt) LMGP / LM1-057A. -16 to -24 C

Analyzing Compounds of Environmental Interest Using an LC/Q-TOF Part 1: Dyes and Pigments. Application. Introduction. Authors. Abstract.

COMPLEX HEROIN COMPARISON INVESTIGATION

Using UHPLC-Triple Quadrupole MS/MS to Detect the Presence of Bark Extract and Yohimbine Adulteration in Dietary Supplements and Botanicals

1-(1,3-benzodioxol-5-yl)-2-(ethylamino)hexan-1-one

NCFS Sample Preparation and Instrumental Parameters

Supplementary Information

N-(1-carbamoyl-2-methyl-propyl)-1-(5-chloropentyl)indazole-3- carboxamide

Accelerating the Metabolite Identification Process Using High Resolution Q-TOF Data and Mass-MetaSite Software

A Fast and Sensitive Method for Residual Hydrazine Analysis in Pharmaceutical Samples

Metabolomics Batch Data Analysis Workflow to Characterize Differential Metabolites in Bacteria

RESPONSE PROJECT DATABASE - NPS AND RELATED COMPOUNDS

5-METHOXY- -METHYLTRYPTAMINE Latest revision: June 20, 2005

Supporting Information

Accurate Mass Measurement for Intact Proteins using ESI-oa-TOF. Application Note. Donghui Yi and Christine Miller Agilent Technologies

637. Thiamethoxam. HPLC method

Separation of Enantiomers of Amphetamine-Related Drugs and Their Structural Isomers

Transcription:

Vodovodna 95 1000 Ljubljana SLOVENIJA T: +386 (0)1 428 44 93 E: nfl@policija.si www.policija.si Remark other NPS detected: none ANALYTICAL REPORT 1 5F-AKB48 (C23H30FN3O) N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3 carboxamide Sample ID: 1179-15 Sample description: powder - white Sample type: seized /Customs Date of sample receipt (M/D/Y): 5/25/2015 Date of entry (M/D/Y) into NFL database: 6/3/2015 Report updates (if any) will be published here: http://www.policija.si/apps/nfl_response_web/seznam.php Substance identified - structure 2 (base form) Systematic name Other names Formula (per base form) N-(1-adamantyl)-1-(5-fluoropentyl)-1H-indazole-3 carboxamide APINACA 5-fluoropentyl analog; 5F-APINACA C23H30FN3O M w (g/mol) 383,51 Salt form/anions detected StdInChIKey Compound Class Other NPS detected Add.info (purity..) base UCMFSGVIEPXYIV-UHFFFAOYSA-N Cannabinoids none residual solvents detected by NMR and confirmed by SPME technique (diisopropylether) 1 This report has been produced with the financial support of the P r e v e n t i o n o f a n d f i g h t a g a i n s t c r i m e Programme of the European Union (grant agreement number JUST/2013/ISEC/DRUGS/AG/6413). The contents of this report are the sole responsibility of the National Forensic Laboratory and can in no way be taken to reflect the views of the European Commission. 2 Created by OPSIN free tool: http://opsin.ch.cam.ac.uk/ DOI: 10.1021/ci100384d Stran 1 od 6 ID1179

Stran 2 od 6 ID 1179

Report updates date comments (explanation) Instrumental methods (if applied) in NFL 1. GC-MS (Agilent): GC-method is RT locked to tetracosane (RT=9.53 min). Injection volume 1 ml and split mode (1:50). Injector temperature: 280 0 C. Chromatographic separation: on column HP1-MS (100% dimethylpolysiloxane), length 30 m, internal diameter 0.25 mm, film thickens 0.25 mm. Carrier gas He: flow-rate 1.2 ml/min. GC oven program: 170 0 C for 1 min, followed by heating up to 293 0 C at a rate of 18 0 C/min, hold for 6.1 min, than heating at 50 0 C/min up to 325 0 C and finally 6.1 min isothermal. MSD source EI = 70 ev. GC-MS transfer line T= 235 0 C, source and quadropole temperatures 280 0 C and 180 0 C, respectively. Scan range m/z scan range: from 50 (30 until 6 min.) to 550 (300) amu. 2. HPLC-TOF (Agilent): 6230B TOF with Agilent 1260 Infinity HPLC with binary pump, column: Zorbax Eclipse XDB-C18, 50 x 4.6 mm, 1.8 micron. Mobile phases (A) 0.1% formic acid and 1mM ammonium formate in water; (B) 0.1% formic acid in methanol (B). Gradient: starting at 5% B, changing to 40% B over 4 min, then to 70% over 2 min and in 5 min to 100%, hold 1 min and back to 5%, equilibration for 1.7 min. The flow rate: 1.0 ml/min; Injection volume 1 µl. MS parameters: 2GHz, Extended Dynamic range mode to a maximum of 1700 amu, acquisition rate 1.30 spectra/sec. Sample ionisation: by Agilent Jet Stream technology (Dual AJS ESI). Ion source: positive ion scan mode with mass scanning from 82 to 1000 amu. Other TOF parameters: drying gas (N2) and sheath temperature 325 C; drying gas flow rate 6 l/min; sheath gas flow rate 8 l/min; nebulizer 25 psig; Vcap. 4000 V; nozzle 2000 V; skimmer 65 V; fragmentor 175 V and Octopole RF 750 V. 3.FTIR-ATR (Perkin Elmer): scan range 4000-400 cm-1; resolution 4cm-1 4. GC- (MS)-IR condensed phase (GC-MS (Agilent) & IR (Spectra analyses-danny) GC-method: Injection volume 1 ml and split mode (1:5). Injector temperature 280 0 C. Chromatographic separation as above (1). Split MS : IR = 1:9. MSD source EI = 70 ev. GC-MS transfer line T= 235 0 C, source and quadropole temperatures 280 0 C and 180 0 C, respectively. Scan range m/z scan range: from 50 (30 until 6 min.) to 550 (300) amu. IR (condesed phase): IR scan range 4000 to 650, resolution 4 cm -1. 5. IC (anions) (Thermo Scientific, Dionex ICS 2100), Column: IonPac AS19, 2 x 250mm; Eluent: 10mM from 0 to 10 min, 10-58 mm from 10 to 40min; Flow rate: 0.25 ml/min; Temperature: 30 C; Suppressor: AERS 500 2mm, suppressor current 13mA; Inj. Volume: 25 µl Stran 3 od 6 ID 1179

Supporting information Solubility in CH 2 Cl 2 MeOH H 2 O result/remark soluble soluble Analytical technique: applied remarks GC-MS (EI ionization) + NFL GC-RT (min): 15,65 BP(1): 233; BP(2): 145,BP(3) :294, HPLC-TOF + Exact mass (theoretical): 383,2373; measured value Δppm:-0,24; formula:c23h30fn3o FTIR-ATR + direct measurement FTIR (condensed phase) always as base form IC (anions) - spot tests only NMR (in FKKT) + validation other + FTIR-ATR (after solvents evaporation consistent) by SWGDRUG library Lot#N1P53EMG (QU>0.99) Stran 4 od 6 ID 1179

ANALYTICAL RESULTS MS (EI) Stran 5 od 6 ID 1179

FTIR-ATR - direct measurement (residual solvents evaporated at room T) IR (condensed phase after chromatographic separation) Stran 6 od 6 ID 1179

Target Compound Screening Report Data File 5F-AKB48_ID 1179_TOF.d Sample Name 5F-AKB48 Sample Type Sample Position P1-A2 Instrument Name SG13170002 User Name Acq Method droge general-13-5-2015-xdb-c18-esi-poz.m Acquired Time 5/27/2015 11:53:15 AM IRM Calibration Status Success DA Method Droge_Default.m Comment extract in MeOH Compound Table Label Cpd 8: 5F-AKB48_ID_1179-15 Tgt Name 5F-AKB48_ID_1179-15 MFG Formula C23 H30 F N3 O Tgt Formula C23 H30 F N3 O Obs. RT 10.65 Obs. Mass 383.2374 Name 5F-AKB48_ID_1179-15 Obs. m/z 384.2445 10.65 Obs. RT Obs. Mass 383.2374 DB RT 10.65 DB Formula C23 H30 F N3 O DB Mass 383.2373 DB Mass Error -0.24 Tgt Formula C23 H30 F N3 O Find Cpds Algorith Find by Molecula r Feature Compound Chromatograms MFE MS Zoomed Spectrum MS Zoomed Spectrum MS Spectrum Peak List Obs. m/z Charge 384.2445 1 385.2482 1 386.2509 1 387.255 1 406.2264 1 407.2297 1 767.481 1 768.4844 1 789.4633 1 790.466 1 --- End Of Report --- Abund Formula 2667331 C23 H30 F N3 O 676387.85 C23 H30 F N3 O 83303.44 C23 H30 F N3 O 9001.77 C23 H30 F N3 O 137104.8 C23 H30 F N3 O 33450.91 C23 H30 F N3 O 21695.41 11873.9 56882.85 29157.46 Ion/Isotope (M+H)+ (M+H)+ (M+H)+ (M+H)+ (M+Na)+ (M+Na)+ (2M+H)+ (2M+H)+ (2M+Na)+ (2M+Na)+ Page 1 of 1 Printed at: 1:10 PM on:5/27/2015

University of Ljubljana Faculty of Chemistry and Chemical Technology Večna pot 113 P. O. Box 537 SI-1001 Ljubljana Slovenia Phone: +386 1 479 8558 janez.kosmrlj@fkkt.uni-lj.si R E P O R T Sample ID: 1179-15 Our notebook code: NMR sample preparation: 15 mg dissolved in 0.7 ml CDCl 3 15 mg dissolved in 0.7 ml DMSO 6 NMR experiments: 1 H, 13 C, 19 F, 1 H 1 H gs-cosy, 1 H 13 C gs-hsqc, 1 H 13 C gs-hmbc, 1 H 15 N gs-hmbc. All experiments in both indicated solvents. Proposed structure with chemical name: Comments: - Structure elucidation based on 1D and 2D NMR spectra - An impurity is detected in 1 H and 13 C NMR spectra. Based on the comparison with the SDBS database, the impurity is most likely diisopropyl ether (B) in the ratio A : B of 1 : 0.07. Less likely the impurity is 2-propanol (C) in the ration A : C of 1 : 0.14. Supporting information: Copies of 1 H and 13 C NMR spectra in CDCl 3 and DMSO 6 Author: Prof. Dr. Janez Košmrlj Date of report: June 2, 2015 This report has been produced with the financial support of the P r e v e n t i o n o f a n d f i g h t a g a i n s t c r i m e Programme of the European Union (grant agreement number JUST/2013/ISEC/DRUGS/AG/6413). The contents of this publication are the sole responsibility of the Author and can in no way be taken to reflect the views of the European Commission. 1

162.00 138.13 140.85 122.36 122.82 123.16 126.61 108.98 76.78 77.03 77.28 83.07 84.38 68.33 49.03 51.84 41.87 22.65 22.69 22.86 29.37 29.55 29.84 29.99 36.46-0.00 1.00 1.35 2.07 1.00 3.12 1.08 0.15 8.75 2.14 3.22 6.25 2.14 0.94 1H, CDCl3 Current Data Parameters NAME EXPNO 1 PROCNO 1 F2 - Acquisition Parameters Date_ 20150530 Time 14.05 INSTRUM spect PROBHD 5 mm PABBO BB- PULPROG zg30 TD 65536 SOLVENT CDCl3 NS 16 DS 2 SWH 10330.578 Hz FIDRES 0.157632 Hz AQ 3.1719923 sec RG 64 DW 48.400 usec DE 6.50 usec TE 296.0 K D1 1.00000000 sec ======== CHANNEL f1 ======== NUC1 1H P1 8.90 usec PLW1 26.00000000 W SFO1 500.1330885 MHz F2 - Processing parameters SI 65536 SF 500.1300123 MHz WDW EM SSB 0 LB 0.30 Hz GB 0 PC 1.00 9 8 7 6 5 4 3 2 1 ppm 13C, CDCl3 Current Data Parameters NAME EXPNO 7 PROCNO 1 F2 - Acquisition Parameters Date_ 20150531 Time 13.19 INSTRUM spect PROBHD 5 mm PABBO BB- PULPROG zgpg30 TD 65536 SOLVENT CDCl3 NS 10240 DS 4 SWH 29761.904 Hz FIDRES 0.454131 Hz AQ 1.1010548 sec RG 2050 DW 16.800 usec DE 6.50 usec TE 296.0 K D1 1.00000000 sec D11 0.03000000 sec ======== CHANNEL f1 ======== NUC1 13C P1 9.00 usec PLW1 122.00000000 W SFO1 125.7703637 MHz ======== CHANNEL f2 ======== CPDPRG2 waltz16 NUC2 1H PCPD2 80.00 usec PLW2 26.00000000 W PLW12 0.32179001 W PLW13 0.20595001 W SFO2 500.1320005 MHz F2 - Processing parameters SI 32768 SF 125.7577902 MHz WDW EM SSB 0 LB 1.00 Hz GB 0 PC 1.40 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm

161.12 137.50 140.63 121.88 121.93 122.25 126.54 110.33 83.01 84.30 67.31 48.42 51.12 22.02 22.06 22.80 28.91 29.05 29.26 29.41 35.98 39.50 41.11 1.00 1.01 0.98 1.03 1.02 1.05 3.07 0.12 8.25 2.10 3.22 6.00 2.07 0.78 1H, DMSO-d6 Current Data Parameters NAME EXPNO 20 PROCNO 1 F2 - Acquisition Parameters Date_ 20150530 Time 14.11 INSTRUM spect PROBHD 5 mm PABBO BB- PULPROG zg30 TD 65536 SOLVENT DMSO NS 16 DS 2 SWH 10330.578 Hz FIDRES 0.157632 Hz AQ 3.1719923 sec RG 64 DW 48.400 usec DE 6.50 usec TE 296.0 K D1 1.00000000 sec ======== CHANNEL f1 ======== NUC1 1H P1 8.90 usec PLW1 26.00000000 W SFO1 500.1330885 MHz F2 - Processing parameters SI 65536 SF 500.1300012 MHz WDW EM SSB 0 LB 0.30 Hz GB 0 PC 1.00 9 8 7 6 5 4 3 2 1 ppm 13C, DMSO-d6 Current Data Parameters NAME EXPNO 26 PROCNO 1 F2 - Acquisition Parameters Date_ 20150531 Time 1.47 INSTRUM spect PROBHD 5 mm PABBO BB- PULPROG zgpg30 TD 65536 SOLVENT DMSO NS 10240 DS 4 SWH 29761.904 Hz FIDRES 0.454131 Hz AQ 1.1010548 sec RG 2050 DW 16.800 usec DE 6.50 usec TE 296.0 K D1 1.00000000 sec D11 0.03000000 sec ======== CHANNEL f1 ======== NUC1 13C P1 9.00 usec PLW1 122.00000000 W SFO1 125.7703637 MHz ======== CHANNEL f2 ======== CPDPRG2 waltz16 NUC2 1H PCPD2 80.00 usec PLW2 26.00000000 W PLW12 0.32179001 W PLW13 0.20595001 W SFO2 500.1320005 MHz F2 - Processing parameters SI 32768 SF 125.7578464 MHz WDW EM SSB 0 LB 1.00 Hz GB 0 PC 1.40 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm